Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03SVG
|
|||
| Former ID |
DIB016035
|
|||
| Drug Name |
GSK-2189242A
|
|||
| Synonyms |
Streptococcus pneumoniae adult vaccine, GlaxoSmithKline
Click to Show/Hide
|
|||
| Indication | Pneumococcal infection [ICD-11: CA00-CA40; ICD-10: A00-B99; ICD-9: 001-139] | Phase 2 | [1] | |
| Company |
Glaxosmithkline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01262872) Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.